These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 1332952
1. Purification and characterization of heparin lyases from Flavobacterium heparinum. Lohse DL, Linhardt RJ. J Biol Chem; 1992 Dec 05; 267(34):24347-55. PubMed ID: 1332952 [Abstract] [Full Text] [Related]
2. Purification and characterization of a novel heparinase. Böhmer LH, Pitout MJ, Steyn PL, Visser L. J Biol Chem; 1990 Aug 15; 265(23):13609-17. PubMed ID: 2166036 [Abstract] [Full Text] [Related]
3. Purification, characterization and specificity of chondroitin lyases and glycuronidase from Flavobacterium heparinum. Gu K, Linhardt RJ, Laliberté M, Gu K, Zimmermann J. Biochem J; 1995 Dec 01; 312 ( Pt 2)(Pt 2):569-77. PubMed ID: 8526872 [Abstract] [Full Text] [Related]
4. Purification and characterization of heparinase from Flavobacterium heparinum. Yang VC, Linhardt RJ, Bernstein H, Cooney CL, Langer R. J Biol Chem; 1985 Feb 10; 260(3):1849-57. PubMed ID: 3968088 [Abstract] [Full Text] [Related]
5. Examination of the substrate specificity of heparin and heparan sulfate lyases. Linhardt RJ, Turnbull JE, Wang HM, Loganathan D, Gallagher JT. Biochemistry; 1990 Mar 13; 29(10):2611-7. PubMed ID: 2334685 [Abstract] [Full Text] [Related]
6. Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy. Nader HB, Porcionatto MA, Tersariol IL, Pinhal MA, Oliveira FW, Moraes CT, Dietrich CP. J Biol Chem; 1990 Oct 05; 265(28):16807-13. PubMed ID: 2211596 [Abstract] [Full Text] [Related]
7. Opposite effects of basic fibroblast growth factor and heparin on heparin/heparan sulfate degrading enzymes from Flavobacterium heparinum. Cavari S, Vannucchi S. Biochem Mol Biol Int; 1996 Jul 05; 39(4):823-31. PubMed ID: 8843352 [Abstract] [Full Text] [Related]
8. Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum. Ernst S, Venkataraman G, Winkler S, Godavarti R, Langer R, Cooney CL, Sasisekharan R. Biochem J; 1996 Apr 15; 315 ( Pt 2)(Pt 2):589-97. PubMed ID: 8615834 [Abstract] [Full Text] [Related]
9. Specificity studies on the heparin lyases from Flavobacterium heparinum. Desai UR, Wang HM, Linhardt RJ. Biochemistry; 1993 Aug 17; 32(32):8140-5. PubMed ID: 8347612 [Abstract] [Full Text] [Related]
10. Substrate specificity of the heparin lyases from Flavobacterium heparinum. Desai UR, Wang HM, Linhardt RJ. Arch Biochem Biophys; 1993 Nov 01; 306(2):461-8. PubMed ID: 8215450 [Abstract] [Full Text] [Related]
11. Action pattern of polysaccharide lyases on glycosaminoglycans. Jandik KA, Gu K, Linhardt RJ. Glycobiology; 1994 Jun 01; 4(3):289-96. PubMed ID: 7949654 [Abstract] [Full Text] [Related]
12. Purification and properties of Bacteroides heparinolyticus heparinase (heparin lyase, EC 4.2.2.7). Nakamura T, Shibata Y, Fujimura S. J Clin Microbiol; 1988 May 01; 26(5):1070-1. PubMed ID: 3384902 [Abstract] [Full Text] [Related]
13. Cloning and expression of heparinase I gene from Flavobacterium heparinum. Sasisekharan R, Bulmer M, Moremen KW, Cooney CL, Langer R. Proc Natl Acad Sci U S A; 1993 Apr 15; 90(8):3660-4. PubMed ID: 8475114 [Abstract] [Full Text] [Related]
14. Large scale preparation and characterization of mucopolysaccharase contamination free heparinase. Yang VC, Bernstein H, Cooney CL, Langer R. Appl Biochem Biotechnol; 1987 Apr 15; 16():35-50. PubMed ID: 3504129 [Abstract] [Full Text] [Related]
15. Purification of heparinase and heparitinase by affinity chromatography on glycosaminoglycan-bound AH-Sepharose 4B. Ototani N, Kikuchi M, Yosizawa Z. Carbohydr Res; 1981 Feb 02; 88(2):291-303. PubMed ID: 7214377 [Abstract] [Full Text] [Related]
16. New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin. Nader HB, Kobayashi EY, Chavante SF, Tersariol IL, Castro RA, Shinjo SK, Naggi A, Torri G, Casu B, Dietrich CP. Glycoconj J; 1999 Jun 02; 16(6):265-70. PubMed ID: 10579695 [Abstract] [Full Text] [Related]